$RPRX REPROS THERAPEUTICS INC. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REPROS THERAPEUTICS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in REPROS THERAPEUTICS INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
REPROS THERAPEUTICS INC. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Anderson Katherine | CHIEF FINANCIAL OFFICER | 0 | 0 | Jan 31 2018 | |||
| Anderson Katherine | Chief Financial Officer | 0 | 0 | Feb 09 2015 | |||
| CAIN DANIEL F | Director | 27,779 | 33,890 | Jan 31 2018 | |||
| CAIN DANIEL F | Director | 2,000 | 2,440 | Feb 09 2015 | |||
| CAIN DANIEL F | Director | 11,000 | 13,420 | Jan 10 2014 | |||
| Efficacy Capital, Ltd. | 10% Owner | 3,095,136 | 3,776,066 | Dec 02 2009 | |||
| Efficacy Capital, Ltd. | 10% Owner | 0 | 0 | Nov 02 2007 | |||
| Efficacy Capital, Ltd. | 10% Owner | 1,801,913 | 2,198,334 | Dec 05 2007 | |||
| Efficacy Capital, Ltd. | 10% Owner | 2,552,233 | 3,113,724 | Dec 21 2009 | |||
| FOURCROY JEAN L MD PHD MPH | Director | 600 | 732 | Jun 14 2012 | |||
| FOURTEAU PATRICK | Director | 27,779 | 33,890 | Jan 31 2018 | |||
| Harder Jeffrey R | Director | 8,499 | 10,369 | May 23 2008 | |||
| Harder Jeffrey R | Director | 400 | 488 | Nov 19 2008 | |||
| Howell Stephen B. | Director | 0 | 0 | May 22 2009 | |||
| Lammers Paul | President | 0 | 0 | Feb 27 2009 | |||
| Lappe Mark | Director | 4,292,136 | 5,236,406 | May 22 2009 | |||
| LAVOTHA ZSOLT E | Director | 0 | 0 | Oct 01 2004 | |||
| Masterson Nola E | Director | 27,779 | 33,890 | Jan 31 2018 | |||
| Masterson Nola E | Director | 3,355 | 4,093 | Jun 21 2013 | |||
| PERCEPTIVE ADVISORS LLC | 10% Owner | 2,862,560 | 3,492,323 | May 15 2012 | |||
| PERCEPTIVE ADVISORS LLC | 10% Owner | 812,560 | 991,323 | Mar 20 2013 | |||
| PLOTH LOUIS JR | VP & Chief Financial Officer | 0 | 0 | Mar 31 2004 | |||
| PLOTH LOUIS JR | VP & Chief Financial Officer | 0 | 0 | Oct 01 2004 | |||
| PLOTH LOUIS JR | VP & Chief Financial Officer | 32,722 | 39,921 | Apr 05 2005 | |||
| PLOTH LOUIS JR | VP & Chief Financial Officer | 38,217 | 46,625 | Feb 20 2009 | |||
| PLOTH LOUIS JR | VP & Chief Financial Officer | 41,017 | 50,041 | Oct 07 2008 | |||
| PODOLSKI JOSEPH | President and CEO | 107,422 | 131,055 | Dec 09 2016 | |||
| PODOLSKI JOSEPH | President & CEO | 94,181 | 114,901 | Aug 18 2004 | |||
| PODOLSKI JOSEPH | President and CEO | 99,881 | 121,855 | Jan 03 2006 | |||
| PODOLSKI JOSEPH | President and CEO | 55,945 | 68,253 | Mar 06 2012 | |||
| PODOLSKI JOSEPH | President and CEO | 0 | 0 | Sep 07 2012 | |||
| PODOLSKI JOSEPH | President and CEO | 58,945 | 71,913 | Mar 27 2014 | |||
| PODOLSKI JOSEPH | President and CEO | 61,045 | 74,475 | Aug 14 2014 | |||
| PODOLSKI JOSEPH | President and CEO | 65,745 | 80,209 | Nov 12 2014 | |||
| Poorvin David | Director | 0 | 0 | May 15 2008 | |||
| Ramasastry Saira | Director | 27,779 | 33,890 | Jan 31 2018 | |||
| Ramasastry Saira | Director | 0 | 0 | Jun 21 2013 | |||
| Ramasastry Saira | Director | 0 | 0 | Feb 09 2015 | |||
| REED JOHN C | Director | 0 | 0 | May 22 2009 | |||
| Suesserman Michael | Director | 0 | 0 | Jun 01 2015 | |||
| Thompson Jaye | See Remarks | 0 | 0 | Jul 06 2016 | |||
| van As Andre MD, PhD | Chief Medical Officer | 10,000 | 12,200 | Apr 16 2009 | |||
| Wernicke J. F. | Chief Medical Officer | 10,000 | 12,200 | Jul 06 2016 | |||
| Wiehle Ronald | Vice President, R&D | 0 | 0 | Mar 02 2011 | |||
| Wiehle Ronald | VP, Research and Development | 0 | 0 | Mar 27 2014 | |||
| Wyllie Michael | Director | 27,779 | 33,890 | Jan 31 2018 | |||
| Wyllie Michael | Director | 9,359 | 11,418 | Feb 09 2015 | |||
| Wyllie Michael | Director | 0 | 0 | Jun 17 2014 |